Literature DB >> 17363185

Randomized comparison of dry dressings versus hydrogel in management of radiation-induced moist desquamation.

Maureen S Macmillan1, Mary Wells, Sheila MacBride, Gillian M Raab, Alastair Munro, Hugh MacDougall.   

Abstract

PURPOSE: We present the results of a randomized controlled clinical trial that evaluated the effect of a hydrogel or dry dressing on the time to healing of moist desquamation after radiotherapy to the head-and-neck, breast, or anorectal areas. METHODS AND MATERIALS: A total of 357 patients were randomized before radiotherapy to receive simple dry dressings (Tricotex) or a hydrogel (Intrasite), with Tricotex as a secondary dressing. Patients were instructed to use their dressings from the onset of moist desquamation, if it occurred.
RESULTS: Of the 357 patients, 100 (28%) developed moist desquamation. The time to healing was significantly prolonged (hazard ratio, 0.64; 95% confidence interval, 0.42-0.99), in patients assigned to gel dressings. No evidence was found that gel dressings had a significant impact on subjectively reported skin symptoms.
CONCLUSION: The results of this study have not supported the routine use of hydrogels in the care of patients with moist desquamation and suggests that the healing times are prolonged, without any improvement in patient comfort.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17363185     DOI: 10.1016/j.ijrobp.2006.12.049

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  9 in total

Review 1.  Clinical practice guidelines for the prevention and treatment of acute and late radiation reactions from the MASCC Skin Toxicity Study Group.

Authors:  Rebecca K S Wong; René-Jean Bensadoun; Christine B Boers-Doets; Jane Bryce; Alexandre Chan; Joel B Epstein; Beth Eaby-Sandy; Mario E Lacouture
Journal:  Support Care Cancer       Date:  2013-08-14       Impact factor: 3.603

Review 2.  A systematic review of patient-rated measures of radiodermatitis in breast cancer radiotherapy.

Authors:  Julie B Schnur; Bianca Love; Bari L Scheckner; Sheryl Green; A Gabriella Wernicke; A Gabriella; Guy H Montgomery
Journal:  Am J Clin Oncol       Date:  2011-10       Impact factor: 2.339

3.  Prophylaxis and management of acute radiation-induced skin reactions: a systematic review of the literature.

Authors:  N Salvo; E Barnes; J van Draanen; E Stacey; G Mitera; D Breen; A Giotis; G Czarnota; J Pang; C De Angelis
Journal:  Curr Oncol       Date:  2010-08       Impact factor: 3.677

Review 4.  Modern Dressings in Prevention and Therapy of Acute and Chronic Radiation Dermatitis-A Literature Review.

Authors:  Konrad Zasadziński; Mateusz Jacek Spałek; Piotr Rutkowski
Journal:  Pharmaceutics       Date:  2022-06-06       Impact factor: 6.525

5.  Dry dressing for epidermal sloughing after subcutaneous azacitidine injection in a myelodysplastic syndrome.

Authors:  Jun Yong Lee; Hyunwook Jung; Ho Kwon; Sung-No Jung
Journal:  Arch Plast Surg       Date:  2014-07-15

Review 6.  Acute radiation dermatitis in breast cancer patients: challenges and solutions.

Authors:  Adam J Kole; Lauren Kole; Meena S Moran
Journal:  Breast Cancer (Dove Med Press)       Date:  2017-05-05

7.  Comparison of the Effect of Alpha and Hydrocortisone Ointments on Prevention of Acute Skin Complications Due to Radiotherapy in Breast Cancer Patients.

Authors:  Mansour Rezaei; Ahmad Khoshay; Nasrin Amirifard; Ali Goli; Alireza Abdi
Journal:  J Skin Cancer       Date:  2021-06-16

8.  A phase III trial comparing an anionic phospholipid-based cream and aloe vera-based gel in the prevention of radiation dermatitis in pediatric patients.

Authors:  Thomas E Merchant; Christina Bosley; Julie Smith; Pam Baratti; David Pritchard; Tina Davis; Chenghong Li; Xiaoping Xiong
Journal:  Radiat Oncol       Date:  2007-12-19       Impact factor: 3.481

Review 9.  Acute and Chronic Cutaneous Reactions to Ionizing Radiation Therapy.

Authors:  Fleta N Bray; Brian J Simmons; Aaron H Wolfson; Keyvan Nouri
Journal:  Dermatol Ther (Heidelb)       Date:  2016-06-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.